{"title":"Causality Assessment of Adverse Events by Healthcare Professionals in an Academic Hospital Setting: A Descriptive Retrospective Study.","authors":"Sonia Corbin, Maude Lavallée, Pallavi Pradhan, Magalie Thibault, Julie Méthot, Laura Blonde Guefack Djiokeng, Anick Berard, Marie-Eve Piché, Fernanda Raphael Escobar Gimenes, Rosalie Darveau, Isabelle Cloutier, Jacinthe Leclerc","doi":"10.1139/cjpp-2024-0268","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Assessing the causality of a drug product-related adverse event (AE) is a very important aspect of pharmacovigilance. However, it is unclear whether AEs are investigated for causality in a hospital setting.</p><p><strong>Objectives: </strong>The aims of this study were to: 1) evaluate the proportion of AEs for which causality is sought and, 2) list the causality assessment (CA) tools used by healthcare professionals.</p><p><strong>Methods: </strong>This retrospective study includes 500 randomized patients (125 patients/year) admitted to a tertiary care academic hospital between 2018-2021. Electronic medical records were reviewed and relevant variables were extracted: 1) demographic, 2) hospitalization, 3) drug product, 4) AE and, 5) CA. A descriptive analysis was carried out (median, minimum-maximum, proportion) to characterize our sample.</p><p><strong>Results: </strong>The characteristic of our sample was as follows: median age 69 years old (range: 21-96 yrs), 43.6% female, median comorbidities/patient 4 (0-12), and median hospital stay of 3 days (1-19). We identified a total of 9,568 drug products and 2,541 AEs, among these, 302 (8.4%) were SAEs. No CA (n=0) or CA tools (n=0) were found in our sample.</p><p><strong>Conclusion: </strong>In this study, we report that no AEs, whether serious or non-serious, were subject to documented CA.</p>","PeriodicalId":9520,"journal":{"name":"Canadian journal of physiology and pharmacology","volume":" ","pages":""},"PeriodicalIF":1.7000,"publicationDate":"2025-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canadian journal of physiology and pharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1139/cjpp-2024-0268","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Assessing the causality of a drug product-related adverse event (AE) is a very important aspect of pharmacovigilance. However, it is unclear whether AEs are investigated for causality in a hospital setting.
Objectives: The aims of this study were to: 1) evaluate the proportion of AEs for which causality is sought and, 2) list the causality assessment (CA) tools used by healthcare professionals.
Methods: This retrospective study includes 500 randomized patients (125 patients/year) admitted to a tertiary care academic hospital between 2018-2021. Electronic medical records were reviewed and relevant variables were extracted: 1) demographic, 2) hospitalization, 3) drug product, 4) AE and, 5) CA. A descriptive analysis was carried out (median, minimum-maximum, proportion) to characterize our sample.
Results: The characteristic of our sample was as follows: median age 69 years old (range: 21-96 yrs), 43.6% female, median comorbidities/patient 4 (0-12), and median hospital stay of 3 days (1-19). We identified a total of 9,568 drug products and 2,541 AEs, among these, 302 (8.4%) were SAEs. No CA (n=0) or CA tools (n=0) were found in our sample.
Conclusion: In this study, we report that no AEs, whether serious or non-serious, were subject to documented CA.
期刊介绍：
Published since 1929, the Canadian Journal of Physiology and Pharmacology is a monthly journal that reports current research in all aspects of physiology, nutrition, pharmacology, and toxicology, contributed by recognized experts and scientists. It publishes symposium reviews and award lectures and occasionally dedicates entire issues or portions of issues to subjects of special interest to its international readership. The journal periodically publishes a “Made In Canada” special section that features invited review articles from internationally recognized scientists who have received some of their training in Canada.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
